The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Carter Martha J. since 2012.
This trader's CIK number is 1213040.
At the time of last reporting, Carter Martha J. was the Chief Regulatory Officer of Albireo Pharma, Inc.. (stock ticker symbol ALBO).
Also see all insider trading activities at Albireo Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | AEGR | 500 | $13,905 | 5,000 | $414,050 | 5,000 | $74,200 |
| 2012 | AEGR | 1,000 | $14,030 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ALBO | 0 | $0 | 938 | $41,181 | 0 | $0 |
| 2022 | ALBO | 0 | $0 | 736 | $18,411 | 0 | $0 |
| 2020 | ALBO | 0 | $0 | 40,000 | $1,672,399 | 40,000 | $921,849 |
1. Aegerion Pharmaceuticals, Inc. (AEGR)
2. Albireo Pharma, Inc. (ALBO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-11-01 | AEGR | Option Ex | 5,000 | 14.84 | 74,200 |
| 2013-11-01 | AEGR | Sale | 5,000 | 82.81 | 414,050 |
| 2013-01-23 | AEGR | Buy | 500 | 27.81 | 13,905 |
| 2012-03-30 | AEGR | Buy | 1,000 | 14.03 | 14,030 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-19 | ALBO | Sale | 938 | 43.90 | 41,181 |
| 2022-10-24 | ALBO | Sale | 104 | 19.58 | 2,035 |
| 2022-07-22 | ALBO | Sale | 106 | 24.68 | 2,615 |
| 2022-04-22 | ALBO | Sale | 103 | 32.92 | 3,391 |
| 2022-01-24 | ALBO | Sale | 423 | 24.52 | 10,370 |
| 2020-09-11 | ALBO | Option Ex | 10,000 | 27.12 | 271,200 |
| 2020-09-11 | ALBO | Sale | 10,000 | 40.03 | 400,300 |
| 2020-09-08 | ALBO | Option Ex | 10,000 | 19.19 | 191,900 |
| 2020-09-09 | ALBO | Option Ex | 10,000 | 21.61 | 216,149 |
| 2020-09-10 | ALBO | Option Ex | 10,000 | 24.26 | 242,600 |
| 2020-09-08 | ALBO | Sale | 10,000 | 45.55 | 455,500 |
| 2020-09-09 | ALBO | Sale | 10,000 | 39.25 | 392,500 |
| 2020-09-10 | ALBO | Sale | 10,000 | 42.41 | 424,099 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carter Martha J. (Chief Regulatory Officer of Albireo Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.